Kane Biotech Inc.

KNBIF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$359$749$1,105$1,153
Short-Term Investments$0$0$0$0
Receivables$88$4$1,057$1,071
Inventory$376$250$763$519
Other Curr. Assets$206$2,720$171$137
Total Curr. Assets$1,029$3,723$3,097$2,880
Property Plant & Equip (Net)$929$1,066$1,252$1,436
Goodwill$0$0$0$0
Intangibles$536$733$826$829
Long-Term Investments$0$0$444$989
Tax Assets$0$0-$444-$989
Other NC Assets$0$159$444$989
Total NC Assets$1,465$1,958$2,523$3,254
Other Assets$0$0$0$0
Total Assets$2,494$5,681$5,620$6,134
Liabilities
Payables$1,186$437$603$626
Short-Term Debt$462$7,084$4,286$2,520
Tax Payable$0$0$0$0
Deferred Revenue$0$0$208$143
Other Curr. Liab.$762$3,373$1,245$1,432
Total Curr. Liab.$2,410$10,894$6,342$4,721
LT Debt$1,713$2,175$2,579$2,203
Deferred Rev, NC$0$191$837$777
Deferred Tax Liab, NC$0$0-$837-$777
Other NC Liab.$0$829$837$777
Total NC Liab.$1,713$3,196$3,416$2,980
Other Liabilities$0$0$0$0
Cap. Leases$873$983$1,088$1,220
Total Liabilities$4,123$14,090$9,758$7,701
Equity
Pref Stock$0$0$0$0
Common Stock$24,402$23,686$23,133$22,156
Retained Earnings-$34,415-$42,134-$37,100-$33,210
AOCI$0$141$0$1,662
Other Equity$8,384$7,749$7,445$5,506
Total Equity-$1,629-$10,558-$6,523-$3,886
Supplemental Information
Minority Interest$0$2,149$2,385$2,319
Total Liab. & Tot. Equity$2,494$5,681$5,620$6,134
Net Debt$1,816$8,510$5,760$3,570
Kane Biotech Inc. (KNBIF) Financial Statements & Key Stats | AlphaPilot